There has been increased discussion in the USA in the past week regarding the extent to which the new Administration will continue to work with companies and organisations who have Diversity, Equality and Inclusion programmes.
Tudor Health would like to assure our business connections that all our current (and future) data is (and will be) collected using data drawn from all relevant HCP and patient cohorts. We will continue to cover all countries and all disease areas, using whatever criteria are relevant in the disease area and country of interest. Similarly, we shall always ensure that all results are shown with the correct levels of representation for each relevant cohort of the population.
We believe applying politically motivated tests to the collection and analysis of healthcare data is potentially dangerous for all involved and will not be party to any such tests being applied to our data.
Our data is sourced from all countries and specifically targets small cohorts and rare diseases, making it perfect for commercial use.
Simply enter your name and email below to receive occasional emails with news and industry insight.*
*Your information will only be used to send our newsletter. It wont be sold or passed to any third party. Obviously, you can unsubscribe at any time!